Moderna launches second phase trial for its coronavirus vaccine
Moderna has dosed its first set of patients in a second phase clinical trial for its coronavirus vaccine, the company announced on Friday. Vaccines are a top-priority for health officials and biotech firms in the battle against coronavirus, as a shot to prevent infection would finally make it safe for people to return to work … Read more